WP
XBI icon

Woodline Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Woodline Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,767
Closed -$1.06M – 763
2023
Q2 		$1.06M Buy
+12,767
New +$1.07M 0.01% 480

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Woodline Partners's XBI Position: Q3 2023 in Review

Woodline Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 12,767 shares — an estimated $1.06M sold.

Woodline Partners first reported a position in XBI in Q2 2023 and held it in 1 quarter. The position peaked at $1.06M in Q2 2023. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

  • Woodline Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Woodline Partners sold 12,767 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $1.06M.
  • Woodline Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 1 quarter.
  • Woodline Partners's State Street SPDR S&P Biotech ETF position peaked at $1.06M in Q2 2023.
  • 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.